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Abstract
Background: Malaria rapid diagnostic tests (RDTs) are now widely used for prompt on-site diagnosis in remote
endemic areas where reliable microscopy is absent. Aberrant results, whereby negative test results occur at high
parasite densities, have been variously reported for over a decade and have led to questions regarding the
reliability of the tests in clinical use.
Methods: In the first trial, serial dilutions of recombinant HRP2 antigen were tested on an HRP2-detectiing RDT. In
a second trial, serial dilutions of culture-derived Plasmodium falciparum parasites were tested against three HRP2-
detecting RDTs.
Results: A prozone-like effect occurred in RDTs at a high concentration of the target antigen, histidine-rich protein-
2 (above 15,000 ng/ml), a level that corresponds to more than 312000 parasites per μL. Similar results were noted
on three RDT products using dilutions of cultured parasites up to a parasite density of 25%. While reduced line
intensity was observed, no false negative results occurred.
Conclusions: These results suggest that false-negative malaria RDT results will rarely occur due to a prozone-like
effect in high-density infections, and other causes are more likely. However, RDT line intensity is poorly indicative
of parasite density in high-density infections and RDTs should, therefore, not be considered quantitative. Immediate
management of suspected severe malaria should rely on clinical assessment or microscopy. Evaluation against high
concentrations of antigen should be considered in malaria RDT product development and lot-release testing, to
ensure that very weak or false negative results will not occur at antigen concentrations that might be seen
clinically.
Background
Rapid and accurate diagnosis is key to effective treat-
ment and management of malaria [1]. The wide use of
lateral flow rapid diagnostic tests (RDT) is essential to
achieve this, as microscopy is impractical in many areas.
T h es a f e t ya n dc r e d i b i l i t yo fm a n yd i a g n o s t i cp r o -
grammes relies therefore on the accuracy of RDTs.
While some RDTs have long proven effective in field
and laboratory studies and more recently in wide-scale
routine use [2-8], false negative results, in particular,
have potential for harming patient health and damaging
the credibility of malaria control programmes. Failure to
detect a case of malaria parasitaemia could lead a clini-
cian to withhold potentially life-saving anti-malarial
therapy that would have been dispensed if non-specific
symptom-based diagnosis had been used.
As is the case for all lateral flow immunochromato-
graphic diagnostic tests, malaria RDTs have limitations
due to their reliance on specific antigen-antibody inter-
actions that can be subject to a range of interfering fac-
tors, and due to other device-related failures and
operator errors. While these devices detect parasite anti-
gen in host blood rather than actual malaria parasites, a
semi-quantitative relationship between parasitaemia and
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some studies [9-12]. However, many factors may affect
the relationship between parasite density and antigen
concentration, and detection of antigen by the lateral
flow device. In addition to variable sensitivity at low
parasite density [4,9,13-15], there have long been reports
of unexplained negative results at high parasite density
[11,16-20]. Possible explanations of these reports have
included gene deletions [21], variation in antigen struc-
ture [22,23], or a prozone-like effect [24-26].
The prozone phenomenon (high dose hook effect) is a
well-recognized phenomenon in a range of immunologic
assays depending on antigen-antibody interactions,
including rapid antibody-detecting immunological diag-
nostic tests. They occur when high antibody concentra-
tion saturates antigen and prevents lattice formation and
precipitation [27-31]. Similar prozone-like effects are
observed with antigen assays for a number of applica-
tions [32-35], and observed in certain malaria tests [24].
A prozone-like effect occurring with malaria RDTs in
patients who have very high parasite density could lead
to inappropriate withholding of antimalarial treatment
to patients who require urgent therapy, with an isolated
case recently being reported [24]. This paper reports an
investigation of the potential of a prozone-like effect to
cause false negative RDT results. The effect of adding
varying amounts of recombinant HRP-2 (rHRP-2) to a
commercially-available malaria RDT designed to detect
this common target antigen was observed, and the study
repeated using high-density culture-derived Plasmodium
falciparum parasites.
Methods
The study was performed in two parts; Trial 1 using
recombinant HRP2 in the Research Institute for Tropi-
cal Medicine, the Philippines, in 2004, and Trial 2 using
cultured P. falciparum in the Army Malaria Institute
(AMI), Australia in 2009.
Trial 1
Preparation of antigen dilutions
To assess the effect on the RDT of very high antigen
concentration, recombinant HRP-2 (National Biopro-
ducts Institute [Dr Martin Bubb], Pinetown, South
Africa) was serially diluted from an initial concentration
of 1.5 mg/mL with parasite-negative type “O” blood
down to 1:100,000, with resultant antigen concentrations
ranging from 1,500,000 ng/mL to 15 ng/mL.
To determine equivalent parasite densities to the
recombinant antigen used, the value of 9.6 ng/mL at 200
parasite/μL is used, based on the median value of 79
infected patients diluted to 200 parasites/μL reported for
the evaluation panel used in the first round of the WHO
product testing programme [36,37]. An ELISA method
had been used to determine these concentrations, as
detailed in version 1 of the Methods Manual for the
WHO product testing programme [38]. This indicates an
equivalent parasite density range of 31 × 10
6 (biologically
implausible) to 313 parasites/μL (Table 1).
RDTs
The serially diluted antigen preparations were tested on
a HRP-2 detecting RDT, Paracheck Pf (Orchid Biomedi-
cal Systems, India; Lot Number 31083A; Expiry 04/
2005), which had been stored at 4°C. The RDT was pre-
pared according to the manufacturer’s instructions, with
micropipettes used to ensure exactly 5 μL of blood from
each antigen dilution was pipetted onto the sample well.
Six drops of buffer were added to the buffer well imme-
diately. After 15 minutes, the results were read visually
by three experienced technicians, comparing the colour
intensity of the test band against a standard RDT rating
chart developed previously by WHO and RITM, rated
from 0 (no band or negative), 1 (very faint) to 4 (strong
line) [39]. The average of the three blinded readings was
recorded for each test. The intensity of each test band
was measured in parallel using a densitometer designed
for lateral flow tests (’Videolab’, Protea-Synteco, Mos-
cow, Russia).
Trial 2
Cultured P. falciparum parasites
Five culture-adapted P. falciparum lines originating
from different geographic areas (GA3, FCR3, SJ44, S55
and 7G8) were cultured in vitro,a sp r e v i o u s l yd e s c r i b e d
[22]. Parasite cultures were repeatedly synchronized
using 5% sorbitol [40], and harvested when parasitaemia
reached ≥10%, with a majority of parasites at ring stage.
The percentage parasitaemia at which parasite lines
SJ44, S55, FCR3, 7G8 and GA3 were harvested were
10%, 16%, 16%, 16% and 17%, respectively. A separate
culture of 7G8 was harvested at a parasitaemia of 25%.
Dilutions of the parasites
An aliquot of each harvested parasite (3% haematocrit)
was serially diluted 10 fold five times using normal red
blood cells at 3% haematocrit. An aliquot of the undi-
luted parasite and each dilution was tested on RDTs. To
imitate the conditions of patient blood, another aliquot
of the harvested parasites was first concentrated to 50%
haematocrit, then serially diluted 10 fold five times
using normal human blood at 50% haematocrit. Aliquots
of the undiluted blood and each of the dilutions were
also tested on RDTs. It should be noted that an undi-
luted culture with 10% parasitaemia at 3% and 50% hae-
matocrit would have ~30000 and ~500000 parasites/μL,
respectively.
Performing rapid diagnostic tests
T h r e eR D T sf o rm a l a r i aw e r eu s e dt ot e s ts e r i a ld i l u -
tions of the cultured parasites: ICT Malaria Combo
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First Response Malaria Antigen pLDH/PfHRP2 Combo
(Cat. No. 116FRC30, Premier Medical Corporation,
India) and SD Malaria Antigen P.f (05FK50, Standard
Diagnostics, Korea). All three tests detect P. falciparum
using antibodies against PfHRP2. The tests were per-
formed according to the manufacturer’si n s t r u c t i o n s .
The results were read by two independent readers and
recorded as levels 0-4 based on the test band intensity
following the same WHO colour reference chart [39].
Ethics approval
The recombinant antigen challenge study was approved
by the Ethics Review Board of the Research Institute for
Tropical Medicine, Philippines. Trial 2, using cultured
parasites, was approved under the Australian Defence
Human Research Ethics Committee approval number
377-05.
Results
Trial 1
Both visual and densitometer readings showed an overall
non-linear relationship with HRP2 concentration and
calculated equivalent parasite density (Figure 1). The
mean visual intensity of the test band increased rapidly
f r o m1( f a i n t )a t1 . 5m g / m Lt o4( s t r o n gb a n d )a t1 , 5 0 0
mg/mL of HRP2, but dropped to only 1.3 as the antigen
concentration reached maximum (1,500,000 ng/mL or
1.5 mg/mL). Densitometer readings showed a trend
similar to the visual readings, with the greatest colour
intensity of the test band using either method observed
between rHRP-2 concentrations of 1,500 - 150,000 ng/
mL (Figure 1). While the intensity of the test band
markedly decreased below the peak intensity at antigen
concentrations above this level, the bands remained
visible.
Assuming that the relationship between parasite den-
sity and antigen concentration remains constant across
parasite densities, the parasite density equivalent to the
HRP2 concentration at which line intensity declined
(15,000 ng/mL) corresponds to >312,500 parasite/μL.
Trial 2
Irrespective of the starting parasite density (measured as
percent of red cells), testing of all undiluted parasite
samples returned a positive result in all 3 RDTs tested.
At parasite densities of 10-16%, the undiluted sample
gave the highest test band intensity, with some diminu-
tion at lower densities. At parasite densities exceeding
17-25% however, the test bands in the undiluted sam-
ples was thinner and qualitatively of reduced intensity
compared to the results seen at the first dilution, an
observation that remained constant irrespective of the
haematocrit of the sample (Table 2), i.e. the peak band
intensity was observed in the 1
st dilution. The band
intensity decreased after the 3
rd dilution.
Discussion
A false negative RDT result, or a failure to appreciate
the severity of P. falciparum infection, may have life-
threatening consequences for a sick individual denied
appropriate treatment. In this study, a marked reduction
in intensity of RDT test lines was observed at high anti-
gen concentration, consistent with a prozone-like effect.
Importantly however, the test band did not totally disap-
pear up to the highest antigen level or parasitaemia
tested (1.5 mg/mL and ~500,000 parasites/μL respec-
tively). The optimum range of HRP-2 concentrations in
terms of line intensity was ~1,500 to 15,000 ng/mL
(equivalent to ~31,250 and ~312,500 parasites/μL
respectively). The results confirm a roughly linear trend
in the relationship between line intensity and antigen
concentration below that level, thus supporting previous
observations of the semi-quantitative properties of RDTs
at lower parasite densities, a relationship that disappears
at higher densities. At antigen concentration above this
range, i.e. 150,000 ng/mL, where the test band intensity
Table 1 Recombinant HRP2 concentrations used in Trial 1, and equivalent parasite densities derived from the median
HRP2 concentration of dilutions of 200 parasite/μL of the WHO global specimen bank
HRP2 concentration
(ng/mL)
Line intensity (densitometer) Mean line intensity
(3 readers)
Calculated parasite density equivalent
(parasite/μL)
15 1.8 1.3 313
150 7.2 3.0 3,125
1,500 16.9 4.0 31,250
15,000 17.9 4.0 312,500
150,000 13.0 3.7 3,125,000
300,000 10.8 3.0 6,250,000
500,000 5.2 2.3 10,416,667
750,000 4.4 2.0 15,625,000
1,000,000 2.4 2.0 20,833,333
1,500,000 1.5 1.0 31,250,000
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sity (Table 1) would be around 3.1 million parasites per
μL of blood, a biologically implausible level. However,
antigen concentration varies widely with peripheral
parasite density. The range of antigen concentration in
the 200 parasite/μL WHO panel is very wide, ranging
from 73.7 ng/mL to 0.8 ng/mL after outliers were
excluded [36]. Taking the higher value, the antigen con-
centration at which test line declined may occasionally
occur at with a parasite density as low as 170,000 para-
sites/μL, which is within the range seen clinically in
some cases of severe malaria. Therefore, while the line
did not disappear at this level providing a false-negative
result, a faint line occurring could mislead a clinician to
overlooking hyperparasitaemia.
The results of Trial 2 using cultured parasites are
broadly consistent with the findings using recombinant
protein: at maximum parasite densities ranging from
10% at 50% haematocrit to 25% at 50% haematocrit
(~500,000 to 1.25 million parasites/μL), the intensity of
lines did not diminish with any of the six different
laboratory strains or with any of the three different
RDTs used. However, some ‘thinning’ of lines indicated
that a prozone-like effect may have been beginning to
impact the results at higher parasite densities.
Gillet et al reported a prozone-like effect in a number
of HRP2-detecting tests at parasitaemias ranging from
5.5% to 35%. These consisted of reduced line intensities
at maximum concentration that resolved after dilution.
Although some line intensities were reported as faint at
high parasite densities, in only a single case (1 of 16
RDT brands at 11.5%) did this result in a test reading
negative [24].
The mechanism underlying the prozone-like effect is
not well defined for antigen-detecting tests. One plausi-
ble explanation is that excess antigen remains unbound
after saturation of the signal monoclonal antibody
( M a b ) ,a n dp a s s e su pt h es t r i pt ob i n dt h ec a p t u r eM a b
on the RDT test line. If this target antigen reaches the
test line in sufficient quantities, it could saturate the
capture antibody, thereby preventing the signal Mab-
antigen complex from binding and accumulating into a
visible band. The likelihood of a false negative result at
high concentration would therefore depend not only on
target antigen concentration (which may vary widely
with parasite density), but also on whether too little cap-
ture antibody is present in the test line of the RDT.
The demonstration here of a weak prozone-like effect
at a very high antigen concentrations and parasite densi-
ties in HRP2-detecting RDTs is consistent with previous
observations. Importantly no false negative results were
observed, and indeed previous observations also suggest
that this is rare. However, a combined effect whereby
the non-linear relationship between antigen
Figure 1 RDT line intensity measured by densitometer and visual rating chart at various dilutions of recombinant HRP2. Note that x-
axis scale is arbitrary.
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quality of RDT manufacture, could combine to result in
a false negative test is conceivable, and in this circum-
stance could lead a clinician to miss a malaria diagnosis,
as demonstrated in the case report quoted earlier[24].
Conclusions
These results and those previously published have a
number of implications. Firstly, RDTs should not be
viewed as quantitative tests. The plateau and fading
effect may mislead the clinician to underestimate a
potentially life-threatening hyperparasitaemia. Secondly,
as recommended by WHO [1], patients with clinically
severe illnesses in malaria-endemic areas should receive
immediate treatment with anti-malarial drugs, and
appropriate antibiotics, and referred for definitive diag-
nosis. Thirdly, the quality of manufacture of RDTs is
likely to influence the likelihood of a prozone-like phe-
nomenon resulting in false negative test results. Thus,
further RDT development, and lot-release testing of
RDTs, could usefully take this into account and include
evaluation against high concentrations of antigen to
ensure that false negative results will not occur at anti-
gen concentrations that might be seen clinically.
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